Cancer hypercalcemia: Recent advances in understanding and treatment

This publication has 33 references indexed in Scilit:

• Absence of Parathyroid Hormone Messenger RNA in Nonparathyroid Tumors Associated with Hypercalcemia
  New England Journal of Medicine, 1983
• COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIA
  The Lancet, 1983
• LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASES
  The Lancet, 1983
• Differential Action of the Bisphosphonates (3-Amino-1-Hydroxypropylidene)-1,1-Bisphosphonate (APD) and Disodium Dichloromethylidene Bisphosphonate (Cl2MDP) on Rat Macrophage-mediated Bone Resorption In Vitro
  Journal of Clinical Investigation, 1982
• Biochemical Evaluation of Patients with Cancer-Associated Hypercalcemia
  New England Journal of Medicine, 1980
• Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
  Journal of Clinical Investigation, 1980
• Epidermal growth factor stimulates prostaglandin production and bone resorption in cultured mouse calvaria
  Biochemical and Biophysical Research Communications, 1978
• Direct resorption of bone by human breast cancer cells in vitro
  Nature, 1978
• Effect of corticosteroids on hypercalc˦mia of malignant disease
  The Lancet, 1971
• FAILURE OF CORTICOSTEROID THERAPY TO CORRECT THE HYPERCALCÆMIA OF MALIGNANT DISEASE
  The Lancet, 1970